
Sarcomatrix Selected as Finalist for Prestigious Start-Up Stadium at BIO International Convention 2025
BOSTON, MA, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- Sarcomatrix Therapeutics Corp., a pioneering biotech company developing oral, mutation-agnostic therapies for muscle-wasting diseases, has been selected as a finalist for the highly …